Skip to content

US · ACONW

Aclarion, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Medical - Healthcare Information Services
Headquarters
Broomfield, CA 80021

Price at previous close

$0.03

Market cap 13.07K

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Aclarion, Inc. (ACONW) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Aclarion, Inc.

        Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.

        CEO
        Brent Ness
        Employees
        11
        Beta
        1.21

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.